Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.
Two recombinant herpesviruses of turkey (HVT) expressing the VP2 protein of infectious bursal disease virus (IBDV or Gumboro disease virus) have been constructed: vHVT001 and vHVT002. The VP2 open reading frame was inserted at the locus of the small subunit of ribonucleotide reductase gene (HSV-1 UL40 homolog) without any exogenous promoter in vHVT001 and at the locus of gl gene (HSV-1 US7 homolog) under the control of the human cytomegalovirus immediate-early promoter in vHVT002. The isolation of these recombinant viruses indicated that the deleted genes were not required for replication of HVT in chicken embryo fibroblasts. Efficacy of these recombinant viruses against IBDV strain 52/70 and Marek's disease virus (MDV strain RB1B) virulent challenges was evaluated in chickens vaccinated at 1 day of age. In the IBDV challenge, a good protection against mortality and bursal gross lesion was observed in vHVT002-vaccinated chickens: 100% with 10(5) PFU dose and 60% with 10(4) PFU dose; in contrast, only a weak level of protection was achieved after vaccination with vHVT001. Protection levels against MDV challenge obtained with vHVT001 and vHVT002 were low (around 10%) compared to that induced by the parental HVT (84%). In spite of the low protection level against MDV, this is the first report which describes induction of full protection against IBDV with a single inoculation of a recombinant virus.
Darteil
R
R
Rhône Mérieux, Laboratoire de Lyon, France.
Bublot
M
M
Laplace
E
E
Bouquet
J F
JF
Audonnet
J C
JC
Rivière
M
M
D000818:Animals; D001483:Base Sequence; D018175:Birnaviridae Infections / Q000276:immunology / Q000517:prevention & control*; D002642:Chick Embryo; D002645:Chickens; D006564:Herpesviridae / Q000235:genetics* / Q000276:immunology; D007243:Infectious bursal disease virus / Q000235:genetics* / Q000472:pathogenicity / Q000502:physiology; D008380:Marek Disease / Q000276:immunology / Q000517:prevention & control; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D014162:Transfection; D014421:Turkey; D014614:Vaccines, Synthetic / Q000627:therapeutic use*; D015678:Viral Structural Proteins / Q000235:genetics* / Q000276:immunology; D014774:Virulence; D014779:Virus Replication
C082513:VP2 protein, infectious bursal disease virus; D014614:Vaccines, Synthetic; D015678:Viral Structural Proteins